Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
While more research is needed, it may lower the risk of heart disease in the long term
Next Steps Semaglutide and tirzepatide are both FDA-approved, well-studied GLP-1 options, while retatrutide remains a promising but investigational medication still working through clinical trials
That is not negotiable
These insights help participants feel more prepared
Foods 57, 453464
Common dosing: 0.11 mg/kg total peptide via subcutaneous injection, split into 10100 g/kg per component
US$ 26.50
US$ 27.64
US$ 28.64
US$ 25.68
